CAS 1800291-86-4

2-[2-[4-[2-[2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy]ethyl]piperazin-1-yl]ethoxy]ethanol

CAS : 1800291-86-4

Couleur et forme : Neat

Ref: 86-MM1130.35

Quetiapine EP Impurity N

CAS : 1800291-86-4

Formule : C₂₉H₄₁N₅O₃S

Masse moléculaire : 539.74

Ref: ST-EA-CP-Q1014

Quetiapine Impurity-N

Produit contrôlé

CAS : 1800291-86-4

Impurity Quetiapine EP Impurity N
Stability Hygroscopic
Applications Quetiapine Impurity-N (Quetiapine EP Impurity N) is a metabolite of Quetiapine, which is approved for the treatment of schizophrenia, bipolar disorder, and along with an antidepressant to treat major depressive disorder.
References Onrust, S., et al.: CNS Drugs, 15, 329 (2001), Lin, S., et al.: J. Anal. Toxicol., 28, 443 (2004), Kirschbaum, K., et al.: Clin. Chem., 51, 1718 (2005), Kinon, B., et al.: J. Clin. Psychopharmacol., 26, 453 (2006),

Formule : C₂₉H₄₁N₅O₃S

Couleur et forme : Light Yellow

Masse moléculaire : 539.73

Ref: TR-Q510015

1-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethyl-2-(1-piperazinyl)ethoxyethanol

CAS : 1800291-86-4

1-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethyl-2-(1-piperazinyl)ethoxyethanol is a synthetic drug that is used as an analytical reference standard and as an impurity standard for drug development. It is a metabolite of the benzodiazepine diazepam, which has been shown to produce significant changes in the activity of GABA receptors. This product has not been evaluated by the FDA and should be used in laboratory research only.

Formule : C₂₉H₄₁N₅O₃S

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 539.73 g/mol

Ref: 3D-ID57891